Institutional investors purchased a net $71.4 thousand shares of NVGN during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 0.84% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JANE STREET CAPITAL LLC Bought 56.9 Thousand shares of Novogen Ltd
KCG AMERICAS LLC Bought 14.8 Thousand shares of Novogen Ltd
CITIGROUP GLOBAL MARKETS, INC. (... Bought 1.4 Thousand shares of Novogen Ltd